AGP Picks
View all

Health News of Alabama: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.

Press releases published on November 2, 2026

Trevi Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 9, 2026
Regeneron Announces Investor Conference Presentations
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Bioventus Reports Third Quarter Financial Results
Relay Therapeutics to Participate in Three Upcoming Investor Conferences in November
Atea Pharmaceuticals to Host Third Quarter 2026 Financial Results and Business Update Conference Call on November 9, 2026
Spero Therapeutics to Present at Investor Conferences in November
OrthoPediatrics to Participate in Upcoming Conferences
Lakefront Biotherapeutics Welcomes Dr. Mehdi Shahidi to its Board of Directors
Lakefront Biotherapeutics verwelkomt Dr. Mehdi Shahidi in haar Raad van Bestuur
CVRx to Participate in Upcoming Investor Conferences
Dianthus Therapeutics to Participate in Five Investor Conferences During November
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results
Xenon to Report Q3 2026 Financial Results on November 9, 2026
Syndax Announces CFO Transition – Aaron A. Ondrey Appointed Chief Financial Officer
Syndax Reports Third Quarter 2026 Financial Results and Provides Business Update
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Assembly Biosciences to Participate in Upcoming Investor Conferences
Avalo Therapeutics to Participate in Upcoming Investor Conferences

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health News of Alabama

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.